Robin Parihar

2.8k total citations
47 papers, 2.3k citations indexed

About

Robin Parihar is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Robin Parihar has authored 47 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Immunology, 33 papers in Oncology and 11 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Robin Parihar's work include Immune Cell Function and Interaction (32 papers), CAR-T cell therapy research (20 papers) and T-cell and B-cell Immunology (15 papers). Robin Parihar is often cited by papers focused on Immune Cell Function and Interaction (32 papers), CAR-T cell therapy research (20 papers) and T-cell and B-cell Immunology (15 papers). Robin Parihar collaborates with scholars based in United States, United Kingdom and Spain. Robin Parihar's co-authors include William E. Carson, Julie Dierksheide, Matthew Dysthe, Julie M. Roda, Susheela Tridandapani, Cynthia M. Magro, Stephen Gottschalk, Cliona M. Rooney, Bilal Omer and Leonid S. Metelitsa and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Robin Parihar

45 papers receiving 2.2k citations

Peers

Countries citing papers authored by Robin Parihar

Since Specialization

Citations

This map shows the geographic impact of Robin Parihar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Parihar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Parihar more than expected).

Fields of papers citing papers by Robin Parihar

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Parihar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Parihar. The network helps show where Robin Parihar may publish in the future.

Co-authorship network of co-authors of Robin Parihar

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Parihar. A scholar is included among the top collaborators of Robin Parihar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Parihar. Robin Parihar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	TIGIT Affects CAR NK-cell Effector Function in the Solid Tumor Microenvironment by Modulating Immune Synapse Strength 2025 ·Cancer Immunology Research ·(unknown), Matthew Dysthe, (unknown), (unknown), Tim Sauer, Navin Varadarajan, Robin Parihar	0
2	Oncolytic adeno-immunotherapy improves allogeneic adoptive HER2.CAR-NK function against pancreatic ductal adenocarcinoma 2025 ·PubMed ·Greyson Biegert, Amanda Rosewell Shaw, Daisuke Morita, Caroline Porter, (unknown), (unknown), (unknown), Mae Woods, (unknown), Robin Parihar, Masataka Suzuki	0
3	NK Cell Therapeutics for Hematologic Malignancies: from Potential to Fruition 2023 ·Current Hematologic Malignancy Reports ·(unknown), (unknown), Robin Parihar	3
4	Selectively targeting myeloid-derived suppressor cells through TRAIL receptor 2 to enhance the efficacy of CAR T cell therapy for treatment of breast cancer 2021 ·Journal for ImmunoTherapy of Cancer ·Saisha Nalawade, Paul Shafer, Pradip Bajgain, Mary K. McKenna, (unknown), (unknown), (unknown), Stephen Gottschalk, Norihiro Watanabe, Ann M. Leen, Robin Parihar, (unknown), Valentina Hoyos	56
5	NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors 2019 ·Cancer Immunology Research ·Robin Parihar, Charlotte Helena Rivas, (unknown), Bilal Omer, Natalia Lapteva, Leonid S. Metelitsa, Stephen Gottschalk, Cliona M. Rooney	219
6	Chimeric Antigen Receptor Signaling Domains Differentially Regulate Proliferation and Native T Cell Receptor Function in Virus-Specific T Cells 2018 ·Frontiers in Medicine ·Bilal Omer, Paul Castillo, Haruko Tashiro, Thomas Shum, (unknown), (unknown), Miyuki Tanaka, (unknown), Tim Sauer, Robin Parihar, Natalia Lapteva, Michael Schmueck‐Henneresse, Malini Mukherjee, Stephen Gottschalk, Cliona M. Rooney	15
7	Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells 2017 ·Cancer Discovery ·Thomas Shum, Bilal Omer, Haruko Tashiro, Robert L. Kruse, Dimitrios L. Wagner, Kathan Parikh, Zhongzhen Yi, Tim Sauer, Daofeng Liu, Robin Parihar, Paul Castillo, Hao Liu, Malcolm K. Brenner, Leonid S. Metelitsa, Stephen Gottschalk, Cliona M. Rooney	220
8	MICA-Expressing Monocytes Enhance Natural Killer Cell Fc Receptor-Mediated Antitumor Functions 2017 ·Cancer Immunology Research ·Amanda R. Campbell, Megan Duggan, Lorena P. Suarez‐Kelly, (unknown), (unknown), Elizabeth L. McMichael, Prashant Trikha, Robin Parihar, (unknown), (unknown), Bryant C. Yung, Robert J. Lee, David H. Raulet, Susheela Tridandapani, Veronika Groh, Lianbo Yu, Vedat Yildiz, John C. Byrd, Michael A. Caligiuri, William E. Carson	15
9	Up-Regulation of iNOS in AML Blasts Creates an Immunosuppressive Microenvironment, Inhibits T-Cell Proliferation and Transforms T-Cells Towards a Tumor-Tolerating Phenotype 2017 ·Blood ·Rodrigo Jácamo, (unknown), (unknown), (unknown), Robin Parihar, Teresa McQueen, Peter P. Ruvolo, Patrick Williams, Gheath Alatrash, Marina Konopleva, Michael Andreeff	3
10	Large-Scale Culture and Genetic Modification of Human Natural Killer Cells for Cellular Therapy 2016 ·Methods in molecular biology ·Natalia Lapteva, Robin Parihar, Lisa Rollins, Adrian P. Gee, Cliona M. Rooney	17
11	IL-12 Enhances the Antitumor Actions of Trastuzumab via NK Cell IFN-γ Production 2011 ·The Journal of Immunology ·Alena Cristina Jaime‐Ramirez, Bethany L. Mundy-Bosse, (unknown), Natalie Jones, Julie M. Roda, Aruna Mani, Robin Parihar, Volodymyr Karpa, Tracey L. Papenfuss, Krista LaPerle, (unknown), Amy Lehman, Abhik Ray Chaudhury, David Jarjoura, Richard W. Burry, William E. Carson	81
12	IL-21 enhances natural killer cell activation in response to antibody-coated tumor cells 2006 ·Cancer Research ·Julie M. Roda, Robin Parihar, Susheela Tridandapani, William E. Carson	1
13	CpG-Containing Oligodeoxynucleotides Act through TLR9 to Enhance the NK Cell Cytokine Response to Antibody-Coated Tumor Cells 2005 ·The Journal of Immunology ·Julie M. Roda, Robin Parihar, William E. Carson	96
14	A Phase I Study of Interleukin 12 with Trastuzumab in Patients with Human Epidermal Growth Factor Receptor-2-Overexpressing Malignancies 2004 ·Clinical Cancer Research ·Robin Parihar, P. Nadella, (unknown), (unknown), (unknown), Julie Dierksheide, Anne M. VanBuskirk, Cynthia M. Magro, Donn C. Young, Charles L. Shapiro, William E. Carson	92
15	The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse 2003 ·Journal of Clinical Investigation ·Gregory B. Lesinski, Mirela Anghelina, Jason M. Zimmerer, (unknown), Brian D. Badgwell, Robin Parihar, Yan Hu, Brian Becknell, Gerard Abood, Abhik Ray Chaudhury, Cynthia M. Magro, Joan E. Durbin, William E. Carson	97
16	IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells 2002 ·Journal of Clinical Investigation ·Robin Parihar, Julie Dierksheide, Yan Hu, William E. Carson	16
17	IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells 2002 ·Journal of Clinical Investigation ·Robin Parihar, Julie Dierksheide, (unknown), William E. Carson	137
18	A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661. 2002 ·PubMed ·Gini F. Fleming, Neal J. Meropol, Gary L. Rosner, Donna Hollis, William E. Carson, Michael A. Caligiuri, Joanne Mortimer, Katherine H. R. Tkaczuk, Robin Parihar, Richard L. Schilsky, Mark J. Ratain	39
19	IL-12 enhances the natural killer cell cytokine response to Ab-coated tumor cells 2002 ·Journal of Clinical Investigation ·Robin Parihar, Julie Dierksheide, (unknown), William E. Carson	156
20	Administration of two macrophage-derived interferon-γ-inducing factors (IL-12 and IL-15) induces a lethal systemic inflammatory response in mice that is dependent on natural killer cells but does not require interferon-γ 2002 ·Cellular Immunology ·(unknown), (unknown), Robin Parihar, Julie Dierksheide, Yanmin Hu, Heinz Baumann, Page Bouchard, Michael A. Caligiuri, William E. Carson	18

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact